Authors:
Bremme, K
van Rooijen, M
Yu, A
Blomback, M
Citation: K. Bremme et al., Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy, BL COAG FIB, 12(2), 2001, pp. 149-155
Authors:
Antovic, J
Bakic, M
Milicevic, R
Gojkovic, G
Blomback, M
Citation: J. Antovic et al., Activation of the coagulation system occurs within rather than outside cutaneous haemangiomas, ACT PAEDIAT, 90(10), 2001, pp. 1137-1140
Citation: Ml. Wramsby et al., Measurement of activated protein C resistance during menstrual cycle in women with and without the Leiden mutation, THROMB HAEM, 85(4), 2001, pp. 614-618
Authors:
Antovic, J
Soderstrom, J
Karlman, B
Blomback, M
Citation: J. Antovic et al., Evaluation of a new immunoturbidimetric test (Liatest (R) antithrombin III) for determination of antithrombin antigen, CLIN LAB H, 23(5), 2001, pp. 313-316
Citation: S. He et al., A simple and rapid laboratory method for determination of haemostasis potential in plasma II. Modifications for use in routine laboratories and research work, THROMB RES, 103(5), 2001, pp. 355-361
Authors:
He, S
Cao, HL
Magnusson, CGM
Eriksson-Berg, M
Mehrkash, M
Schenck-Gustafsson, K
Blomback, M
Citation: S. He et al., Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein, THROMB RES, 103(3), 2001, pp. 241-248
Authors:
Fatah-Ardalani, K
Wallen, P
Petersen, LC
Blomback, M
Citation: K. Fatah-ardalani et al., More porous fibrin gel structure obtained by interaction with Lys-plasminogen than with Glu-plasminogen, BL COAG FIB, 11(4), 2000, pp. 335-342
Authors:
He, S
Wramsby, M
Bokarewa, M
Blomback, M
Bremme, K
Citation: S. He et al., Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy, J THROMB TH, 9(3), 2000, pp. 277-281
Authors:
Wramsby, ML
Bokarewa, MI
Blomback, M
Bremme, AK
Citation: Ml. Wramsby et al., Response to activated protein C during normal menstrual cycle and ovarian stimulation, HUM REPR, 15(4), 2000, pp. 795-797
Citation: B. Blomback et M. Blomback, Recollections of times past: Remembering Inga Marie Nilsson in Stockholm in the '50s, THROMB RES, 98(4), 2000, pp. 231-232
Authors:
Moor, E
Blomback, M
Silveira, A
Wiman, B
Cederlund, K
Bergstrand, L
Ivert, T
Ryden, L
Hamsten, A
Citation: E. Moor et al., Haemostatic function in patients undergoing coronary artery bypass grafting: Peroperative perturbations and relations to saphenous vein graft closure, THROMB RES, 98(1), 2000, pp. 39-49
Citation: S. He et al., Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia?, BL COAG FIB, 10(3), 1999, pp. 127-132
Authors:
He, S
Silveira, A
Hamsten, A
Blomback, M
Bremme, K
Citation: S. He et al., Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia, THROMB HAEM, 81(4), 1999, pp. 538-542
Citation: S. He et al., A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results, THROMB RES, 96(2), 1999, pp. 145-156
Citation: R. Linder et al., Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C, THROMB RES, 95(2), 1999, pp. 117-125
Citation: G. Jorneskog et al., Fibrin gel structure in diabetic patients before and during treatment withacetylsalicylic acid: a pilot study, FIBRINOL PR, 12(6), 1998, pp. 360-365
Authors:
Zhang, ZP
Eriksson, M
Falk, G
Graff, C
Presnell, SC
Read, MS
Nichols, TC
Blomback, M
Anvret, M
Citation: Zp. Zhang et al., Failure to achieve gene conversion with chimeric circular oligonucleotides: Potentially misleading PCR artifacts observed, ANTISENSE N, 8(6), 1998, pp. 531-536